Cencora Past Earnings Performance
Past criteria checks 4/6
Cencora has been growing earnings at an average annual rate of 23.3%, while the Healthcare industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 9.7% per year. Cencora's return on equity is 151%, and it has net margins of 0.7%.
Key information
23.3%
Earnings growth rate
23.9%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 9.7% |
| Return on equity | 151.0% |
| Net Margin | 0.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cencora makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 276,537 | 1,852 | 5,486 | 0 |
| 31 Dec 23 | 271,579 | 1,867 | 5,418 | 0 |
| 30 Sep 23 | 262,173 | 1,745 | 5,310 | 0 |
| 30 Jun 23 | 254,425 | 1,689 | 5,180 | 0 |
| 31 Mar 23 | 247,543 | 1,617 | 5,088 | 0 |
| 31 Dec 22 | 241,805 | 1,729 | 4,970 | 0 |
| 30 Sep 22 | 238,587 | 1,699 | 4,849 | 0 |
| 30 Jun 22 | 236,325 | 1,842 | 4,801 | 0 |
| 31 Mar 22 | 229,666 | 1,727 | 4,502 | 0 |
| 31 Dec 21 | 221,101 | 1,614 | 4,029 | 0 |
| 30 Sep 21 | 213,989 | 1,540 | 3,594 | 0 |
| 30 Jun 21 | 204,321 | -3,744 | 3,062 | 0 |
| 31 Mar 21 | 196,282 | -3,747 | 2,815 | 0 |
| 31 Dec 20 | 194,546 | -3,222 | 2,779 | 0 |
| 30 Sep 20 | 189,894 | -3,409 | 2,767 | 0 |
| 30 Jun 20 | 186,287 | 1,570 | 2,768 | 0 |
| 31 Mar 20 | 186,159 | 1,582 | 2,758 | 0 |
| 31 Dec 19 | 182,061 | 649 | 2,693 | 0 |
| 30 Sep 19 | 179,589 | 855 | 2,664 | 0 |
| 30 Jun 19 | 177,248 | 956 | 2,599 | 0 |
| 31 Mar 19 | 175,151 | 930 | 2,569 | 0 |
| 31 Dec 18 | 172,866 | 1,190 | 2,558 | 0 |
| 30 Sep 18 | 167,940 | 1,658 | 2,460 | 0 |
| 30 Jun 18 | 163,763 | 1,081 | 2,363 | 0 |
| 31 Mar 18 | 159,327 | 855 | 2,262 | 0 |
| 31 Dec 17 | 155,441 | 979 | 2,167 | 0 |
| 30 Sep 17 | 153,144 | 364 | 2,129 | 0 |
| 30 Jun 17 | 151,584 | 855 | 2,098 | 0 |
| 31 Mar 17 | 149,759 | 1,154 | 2,089 | 0 |
| 31 Dec 16 | 148,310 | 1,346 | 2,087 | 0 |
| 30 Sep 16 | 146,850 | 1,428 | 2,091 | 0 |
| 30 Jun 16 | 144,759 | 1,643 | 2,107 | 0 |
| 31 Mar 16 | 142,111 | 1,508 | 2,093 | 0 |
| 31 Dec 15 | 139,082 | 391 | 2,016 | 0 |
| 30 Sep 15 | 135,962 | -138 | 1,908 | 0 |
| 30 Jun 15 | 132,080 | -431 | 1,821 | 0 |
| 31 Mar 15 | 128,195 | -658 | 1,706 | 0 |
| 31 Dec 14 | 123,981 | 35 | 1,640 | 0 |
| 30 Sep 14 | 119,569 | 282 | 1,581 | 0 |
| 30 Jun 14 | 112,449 | 267 | 1,486 | 0 |
| 31 Mar 14 | 104,008 | 344 | 1,430 | 0 |
| 31 Dec 13 | 96,076 | 368 | 1,377 | 0 |
| 30 Sep 13 | 87,959 | 493 | 1,334 | 0 |
| 30 Jun 13 | 82,555 | 633 | 1,305 | 0 |
Quality Earnings: ABG has high quality earnings.
Growing Profit Margin: ABG's current net profit margins (0.7%) are higher than last year (0.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ABG's earnings have grown significantly by 23.3% per year over the past 5 years.
Accelerating Growth: ABG's earnings growth over the past year (14.6%) is below its 5-year average (23.3% per year).
Earnings vs Industry: ABG earnings growth over the past year (14.6%) exceeded the Healthcare industry -7.5%.
Return on Equity
High ROE: Whilst ABG's Return on Equity (150.97%) is outstanding, this metric is skewed due to their high level of debt.